Global Cervical Screening Supply, Demand and Key Producers, 2024-2030

Global Cervical Screening Supply, Demand and Key Producers, 2024-2030

The global Cervical Screening market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Shift towards HPV Testing: Human Papillomavirus (HPV) testing has gained prominence as an effective method for cervical cancer screening. HPV testing is often used in conjunction with or as a replacement for Pap smears due to its higher sensitivity in detecting high-risk HPV strains associated with cervical cancer.

Liquid-Based Cytology: Liquid-based cytology (LBC) has become increasingly popular as an alternative to conventional Pap smears. LBC involves collecting cervical cells in a liquid medium, which can improve sample quality, reduce inadequate samples, and allow for additional testing such as HPV testing or molecular testing.

This report studies the global Cervical Screening demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cervical Screening, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cervical Screening that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Cervical Screening total market, 2019-2030, (USD Million)

Global Cervical Screening total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Cervical Screening total market, key domestic companies and share, (USD Million)

Global Cervical Screening revenue by player and market share 2019-2024, (USD Million)

Global Cervical Screening total market by Type, CAGR, 2019-2030, (USD Million)

Global Cervical Screening total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Cervical Screening market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Hologic, Qiagen, Bio-Rad, BD, Quest Diagnostics, Hybribio and KingMed Diagnostics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cervical Screening market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cervical Screening Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cervical Screening Market, Segmentation by Type
Pap Test
HPV Test

Global Cervical Screening Market, Segmentation by Application
Hospital
Diagnostic Laboratory
Other

Companies Profiled:
Roche Diagnostics
Abbott Laboratories
Hologic
Qiagen
Bio-Rad
BD
Quest Diagnostics
Hybribio
KingMed Diagnostics
Guangdong Hybribio Biotech
Dian Diagnostics
Shanghai ZJ Bio-Tech
Sansure Biotech
Jiangsu Bioperfectus Technologies
Triplex International Biosciences
ACON Biotech

Key Questions Answered

1. How big is the global Cervical Screening market?

2. What is the demand of the global Cervical Screening market?

3. What is the year over year growth of the global Cervical Screening market?

4. What is the total value of the global Cervical Screening market?

5. Who are the major players in the global Cervical Screening market?